ethris.com

Ethris ENABLING mRNA THERAPIES

About Ethris Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary and liver
history traffic contact

OVERVIEW

The website ethris.com presently has a traffic ranking of zero (the smaller the superior). We have inspected four pages inside the web site ethris.com and found eight websites referencing ethris.com. I acquired two contacts and locations for ethris.com to help you connect with them. The website ethris.com has been online for eight hundred and twenty-six weeks, four days, twelve hours, and thirty-eight minutes.
Pages Crawled
4
Links to this site
8
Contacts
2
Addresses
2
Online Since
Aug 2009

ETHRIS.COM TRAFFIC

The website ethris.com is seeing diverging amounts of traffic for the whole of the year.
Traffic for ethris.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ethris.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ethris.com

Date Range

All time
This Year
Last Year
Last Month

ETHRIS.COM HISTORY

The website ethris.com was first documented on August 26, 2009. It was changed on March 06, 2013. This web site will go back on the market on August 26, 2014. As of today, it is eight hundred and twenty-six weeks, four days, twelve hours, and thirty-eight minutes old.
REGISTERED
August
2009
UPDATED
March
2013
EXPIRED
August
2014

COMPANY PERIOD OF EXISTANCE

15
YEARS
10
MONTHS
5
DAYS

LINKS TO DOMAIN

mRNA Health Conference

6th International mRNA Health Conference. We look forward to seeing everyone on Nov 12-13, 2018, at the Royal Sonesta Boston in Cambridge, MA for the 6th International mRNA Health Conference! Further information will follow on this website. Melissa Moore and Josh Frederick from Moderna. Katalin Kariko, Mustafa Diken and Sebastien Kreiter from Biontech.

The cluster of excellence Nanosystems Initiative Munich NIM

Filamentous polymers called microtubules play vital roles in chromosome segregation and molecular transport. NIM scientist Prof Erwin Frey and coworkers have now examined how microtubule lengths vary in response to changes in the availability of their protein components. Dieter Braun receives ERC Advanced Grant. Bacterial adhesion in vitro and in silico. Müller-Buschbaum is the new Scientific Director of the FRM II.

WHAT DOES ETHRIS.COM LOOK LIKE?

Desktop Screenshot of ethris.com Mobile Screenshot of ethris.com Tablet Screenshot of ethris.com

CONTACTS

ethris GmbH

Carsten Rudolph

Ullrich-Haid-Str. 1

Seefeld, unknown, 82229

GERMANY

498917771237
ethris@lrz.tum.de

Host Europe GmbH

Host Europe GmbH

Welserstr. 14

Koeln, DE, 51149

GERMANY

498004678387
support@hosteurope.de

ETHRIS.COM SERVER

I revealed that the main page on ethris.com took one thousand four hundred and twelve milliseconds to stream. Our parsers could not discover a SSL certificate, so we consider this site not secure.
Load time
1.412 secs
SSL
NOT SECURE
Internet Protocol
83.169.26.88

NAME SERVERS

ns1.hans.hosteurope.de
ns2.hans.hosteurope.de

BROWSER ICON

SERVER OS AND ENCODING

We diagnosed that ethris.com is implementing the Apache operating system.

HTML TITLE

Ethris ENABLING mRNA THERAPIES

DESCRIPTION

About Ethris Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary and liver

PARSED CONTENT

The website states the following, "Ethris Enters Strategic Collaboration With AstraZeneca and MedImmune." We viewed that the web site said " Ethris is a technical innovator in the emerging field of messenger RNA therapeutics." It also said " We are using our proprietary technologies to develop a new approach for the treatment of pulmonary and liver diseases. Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Our integrated platform enables the discovery, design and development of transcript therapies. Ethris focus is on the dev."

SEEK SUBSEQUENT BUSINESSES

Ethrix VAS over Cloud

In 2011, almost half a billion new smartphone devices were sold worldwide as well as many tablet devices. These networked devices provide easy access to Internet media and communications services such as Skype and Facebook; c.

Ethrock Cameron DeviantArt

This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. You can edit widgets to customize them.